anmelden
BX Swiss TOP 30 CHF
1.488,58
PKT
+8,29
PKT
+0,56
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.04.05 | Givaudan Equal weight | Lehman Brothers | |
| 11.04.05 | Givaudan Underperform | HypoVereinsbank | |
| 08.04.05 | Novartis Accumulate | Helvea | |
| 08.04.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 08.04.05 | Zurich Insurance Sector Outperform | Vontobel | |
| 08.04.05 | Givaudan Neutral | Helvea | |
| 08.04.05 | Swiss Life Neutral | HypoVereinsbank | |
| 08.04.05 | Zurich Insurance Hold | Dresdner Kleinwort Wasserstein | |
| 12.04.05 | Swiss Life Kaufen | M.M. Warburg | |
| 08.04.05 | Zurich Insurance Accumulate | Helvea | |
| 07.04.05 | Lonza Reduce | Sarasin Research | |
| 07.04.05 | Swiss Life Buy | M.M. Warburg | |
| 07.04.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 07.04.05 | Swiss Life Sell | Merck Finck & Co | |
| 08.04.05 | Swiss Life Underperform | Credit Suisse First Boston | |
| 06.04.05 | Roche Buy | Helvea | |
| 06.04.05 | Swiss Life Sell | Merck Finck & Co | |
| 06.04.05 | Swiss Life Accumulate | Helvea | |
| 07.04.05 | Swiss Life Overweight | Lehman Brothers | |
| 06.04.05 | Swiss Life Overweight | JP Morgan | |
| 07.04.05 | Swiss Life Neutral | Sarasin Research | |
| 06.04.05 | Zurich Insurance Outperform | Goldman Sachs | |
| 05.04.05 | Zurich Insurance Buy | Sarasin Research | |
| 04.04.05 | Givaudan Neutral | Sarasin Research | |
| 04.04.05 | Swiss Life Overweight | JP Morgan | |
| 04.04.05 | Adecco SA Market Outperform | Vontobel | |
| 05.04.05 | Adecco SA Accumulate | Helvea | |
| 05.04.05 | Adecco SA Sell | Dresdner Kleinwort Wasserstein | |
| 04.04.05 | Swiss Life Neutral | Sarasin Research | |
| 01.04.05 | Swisscom Neutral | Helvea | |
| 01.04.05 | Swiss Life Outperform | HypoVereinsbank | |
| 31.03.05 | Swiss Life Overweight | Lehman Brothers | |
| 30.03.05 | Swisscom Neutral | Sarasin Research | |
| 29.03.05 | Roche Buy | Sarasin Research | |
| 24.03.05 | Roche Sector Outperform | Vontobel | |
| 24.03.05 | Swisscom Neutral | Sarasin Research | |
| 22.03.05 | UBS Buy | Merrill Lynch | |
| 22.03.05 | ABB (Asea Brown Boveri) Overweight | JP Morgan | |
| 22.03.05 | Roche Buy | Sarasin Research | |
| 23.03.05 | UBS Neutral | Merrill Lynch |